What does policyholder benefits and claims incurred net mean?

The total costs incurred by the insurer related to policyholder claims and associated adjustment expenses, net of reinsurance recoveries. This represents the primary cost of goods sold for an insurance company. Monitoring this metric is essential for assessing underwriting discipline and the accuracy of actuarial loss reserves.

King Pharmaceuticals KG Policyholder Benefits And Claims Incurred Net

Policyholder Benefits And Claims Incurred Net at other companies

Everest GroupEG

$2.22B-23.4%

Selective Insurance GroupSIGI

$815.5M+9.3%

Reinsurance Group of AmericaRGA

$4.62B+20.9%

Universal Insurance HoldingsUVE

$228.1M-9.0%

Arch Capital GroupACGL

——

W.R. BerkleyWRB

——

Segments

By segment

See full

Legacy Reinsurance$2.26M—

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PolicyholderBenefitsAndClaimsIncurredNet.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's policyholder benefits and claims incurred net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's policyholder benefits and claims incurred net?: King Pharmaceuticals (KG) reported policyholder benefits and claims incurred net of $2.26M in Q1 2026.
What does policyholder benefits and claims incurred net mean?: The total costs incurred by the insurer related to policyholder claims and associated adjustment expenses, net of reinsurance recoveries. This represents the primary cost of goods sold for an insurance company. Monitoring this metric is essential for assessing underwriting discipline and the accuracy of actuarial loss reserves.